Trial Profile
Angiotensin II Blockade and Adipose Tissue Inflammation in Obesity
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms arbfat
- 18 Sep 2012 New trial record